V
VTRS
Viatris Inc Ord Shs
13.44
-0.19-1.39%After Hours: 13.53 +0.09 +0.70%19:59 04/02 EDT
OPEN/PREV CLOSE13.32/13.41
TODAY RANGE13.12-13.39
VOL11.62M
MARKET CAP15.32B
52 WEEK RANGE6.54-16.33
AVG VOL (3M)10.34M
% TURNOVER1.00%
TURNOVER--
P/E (TTM)-4.3832
% RANGE1.98%
EPS(TTM)-3.0024
P/E(FORWARD)56.60
P/B1.030
BVPS12.78
DIVIDEND0.4800
P/S1.059
BETA--
DIV YIELD3.65%
FREE FLOAT MKT CAP15.09B
SHARES OUTSTANDING1.16B
NEXT EARNINGS05/06-05/11
FREE FLOAT1.15B
LOT SIZE1
EX-DATE03/09/2026
News
Press Releases
Financial Reports
Profile
Simply Wall St·1d ago
How Effexor’s New GAD Approval And MR-139 Setback At Viatris (VTRS) Has Changed Its Investment Story
Simply Wall St·4d ago
Viatris (VTRS) Valuation In Focus After MR-139 Phase III Failure And Pipeline Setback
Benzinga·03/31 11:51
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
Simply Wall St·03/29 21:08
Is Effexor’s First-in-Class GAD Approval in Japan Altering The Investment Case For Viatris (VTRS)?
Seeking Alpha·03/28 15:03
Insider trades: CrowdStrike, Palo Alto, Lululemon among notable names
TipRanks·03/28 13:01
TeraWulf, Viatris, MGM, Nucor, Best Buy Shake-Up
TipRanks·03/25 02:03
Top Viatris Executive Makes Notable Move With Insider Stock Sale
Dow Jones·03/24 14:20
Viatris Is Maintained at Overweight by Barclays
Benzinga·03/24 14:10
Barclays Maintains Overweight on Viatris, Raises Price Target to $17
Reuters·03/24 10:24
VIATRIS INC. <VTRS.O>: BARCLAYS RAISES TARGET PRICE TO $17 FROM $15
TipRanks·03/24 09:41
Viatris price target raised to $17 from $15 at Barclays
Reuters·03/24 07:39
U.S. RESEARCH ROUNDUP-Apogee Therapeutics, Insmed, Sunoco
Same Industry
Name/Symbol
Change%
Price